1. Home
  2. PRME vs GRNQ Comparison

PRME vs GRNQ Comparison

Compare PRME & GRNQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRME
  • GRNQ
  • Stock Information
  • Founded
  • PRME 2019
  • GRNQ 2013
  • Country
  • PRME United States
  • GRNQ Malaysia
  • Employees
  • PRME N/A
  • GRNQ N/A
  • Industry
  • PRME Medicinal Chemicals and Botanical Products
  • GRNQ EDP Services
  • Sector
  • PRME Health Care
  • GRNQ Technology
  • Exchange
  • PRME Nasdaq
  • GRNQ Nasdaq
  • Market Cap
  • PRME 191.7M
  • GRNQ 12.7M
  • IPO Year
  • PRME 2022
  • GRNQ 2018
  • Fundamental
  • Price
  • PRME $2.47
  • GRNQ $1.60
  • Analyst Decision
  • PRME Buy
  • GRNQ
  • Analyst Count
  • PRME 6
  • GRNQ 0
  • Target Price
  • PRME $9.38
  • GRNQ N/A
  • AVG Volume (30 Days)
  • PRME 3.1M
  • GRNQ 85.9K
  • Earning Date
  • PRME 08-04-2025
  • GRNQ 08-12-2025
  • Dividend Yield
  • PRME N/A
  • GRNQ N/A
  • EPS Growth
  • PRME N/A
  • GRNQ N/A
  • EPS
  • PRME N/A
  • GRNQ N/A
  • Revenue
  • PRME $3,846,000.00
  • GRNQ $3,190,761.00
  • Revenue This Year
  • PRME $104.12
  • GRNQ N/A
  • Revenue Next Year
  • PRME $196.78
  • GRNQ N/A
  • P/E Ratio
  • PRME N/A
  • GRNQ N/A
  • Revenue Growth
  • PRME 550.76
  • GRNQ N/A
  • 52 Week Low
  • PRME $1.11
  • GRNQ $0.80
  • 52 Week High
  • PRME $6.75
  • GRNQ $2.24
  • Technical
  • Relative Strength Index (RSI)
  • PRME 79.86
  • GRNQ 56.94
  • Support Level
  • PRME $1.56
  • GRNQ $1.47
  • Resistance Level
  • PRME $2.53
  • GRNQ $1.70
  • Average True Range (ATR)
  • PRME 0.25
  • GRNQ 0.18
  • MACD
  • PRME 0.12
  • GRNQ -0.01
  • Stochastic Oscillator
  • PRME 99.21
  • GRNQ 48.19

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management. Its segments include Service business engaged in the provision of corporate advisory and business solution services; Real estate business segment engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia; and Digital business segment engaged in provision of digital platform and trading of digital assets.

Share on Social Networks: